Abstract

http://ssrn.com/abstract=2234212
 


 



Is More Information Always Better? Mandatory Disclosure Regulations in the Prescription Drug Market


Joanna Shepherd


Emory University School of Law

March 1, 2013

Cornell Law Review Online, Vol. 99, 2013
Emory Legal Studies Research Paper No. 13-245

Abstract:     
Pharmacy benefit managers (PBMs) save Americans billions of dollars each year by lowering the prices of prescription drugs and the costs of prescription drug coverage. However, as I explain in this Article, mandatory disclosure regulations recently enacted in several states and under the Affordable Care Act threaten to disrupt the cost savings PBMs currently produce for consumers. These regulations require PBMs to disclose competitively-sensitive financial information to various participants in the prescription drug market. Although mandatory disclosure regulations are premised on the idea that PBM clients can only ensure that they are paying a competitive price for PBM services if they know the specifics of PBMs’ financial arrangements with pharmaceutical manufacturers and pharmacies, there is no theoretical or empirical reason to believe mandated disclosure of this information is necessary. Not only are these regulations unnecessary to achieve competitive outcomes, they also impose significant costs on PBMs. The additional disclosure increases both direct costs and litigation costs for PBMs. More importantly, the regulations foster tacit collusion and reduce PBMs’ ability to negotiate discounts with pharmacies and rebates with drug manufacturers. By disrupting competition in the prescription drug market, mandatory disclosure regulations will ultimately increase the prices that consumers pay for prescription drugs.

Number of Pages in PDF File: 24

Keywords: prescription drug market, pharmacy benefit manager, disclosure, transparency

JEL Classification: I1

Accepted Paper Series


Download This Paper

Date posted: March 16, 2013 ; Last revised: July 3, 2013

Suggested Citation

Shepherd, Joanna, Is More Information Always Better? Mandatory Disclosure Regulations in the Prescription Drug Market (March 1, 2013). Cornell Law Review Online, Vol. 99, 2013; Emory Legal Studies Research Paper No. 13-245. Available at SSRN: http://ssrn.com/abstract=2234212

Contact Information

Joanna Shepherd (Contact Author)
Emory University School of Law ( email )
1301 Clifton Road
Atlanta, GA 30322
United States
404-727-8957 (Phone)
Feedback to SSRN


Paper statistics
Abstract Views: 297
Downloads: 41

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo6 in 0.328 seconds